CDSCO approves ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus September 30, 2023 AstraZeneca Pharma India on Saturday announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL &... Trending JN.1 COVID variant cases rise to 63, total 628 fresh infection What triggers criminals for sudden cold-blooded murders, explains top Psychiatrist Doctor reattaches labour’s hands Latest Facing Vertigo & Balancing Disorder? Get all treatment under one roof at Lajpat Nagar Breakthrough Defence technology SSI Vimana and Project Operion launched Ayurvedic wellness brand Amma Living launched to bring traditional wisdom into everyday life Cancer Awareness, Prevention and Screening camp held at Tis Hazari Court Complex
